Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
Hadassah Medical Organization
National Cancer Institute (NCI)
Bristol-Myers Squibb
Celgene
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center